Browse > Home / Pharmacy Industry News / Swine flu enrich the pharmaceutical companies

Swine flu enrich the pharmaceutical companies

May 7, 2009

Swine flu enrich the pharmaceutical companies, analysts believe

Analysts expect growth in the shares of pharmaceutical companies on Monday morning, following statements by “Roche” and “GlaxoSmithKline”, that they may have to raise millions of doses of vaccine to protect against porcine influenza. Reported “k2kapital” with reference to the edition of “Sunday Telegraph”.

Vaccines “Tamiflu” production “Roche” and “Relenza” production “GSK” has shown its effectiveness against the virus samples of the new disease. The drugs used to protect against outbreaks of avian influenza in Asia and brought the companies make enormous profits. “Roche” has confirmed that she already has 3 million packages “Tamiflu”, ready for use by the World Health Organization.

“I think pharmaceutical companies will grow, but not for long, unless things got out of control”, - said the broker “Killik & Co” Sex Keyvanag.

Written by Samanta · Filed Under Pharmacy Industry News